| Primary |
| Product Used For Unknown Indication |
82.3% |
| Hyperphosphataemia |
11.8% |
| Renal Failure Chronic |
0.9% |
| Anaemia |
0.7% |
| Hypertension |
0.7% |
| Headache |
0.5% |
| Acidosis |
0.2% |
| Antacid Therapy |
0.2% |
| Blood Phosphorus Increased |
0.2% |
| Constipation |
0.2% |
| Device Occlusion |
0.2% |
| Dialysis |
0.2% |
| Hyperparathyroidism Secondary |
0.2% |
| Iron Deficiency |
0.2% |
| Migraine |
0.2% |
| Nausea |
0.2% |
| Pain |
0.2% |
| Prophylaxis |
0.2% |
| Pyrexia |
0.2% |
| Toothache |
0.2% |
|
| Constipation |
34.6% |
| Pruritus |
18.3% |
| Diarrhoea |
8.3% |
| Hyperphosphataemia |
7.0% |
| Nausea |
6.0% |
| Vomiting |
6.0% |
| Overdose |
3.0% |
| Rash |
2.0% |
| Intestinal Obstruction |
1.7% |
| Pruritus Generalised |
1.7% |
| Treatment Noncompliance |
1.7% |
| Dyspepsia |
1.3% |
| Gastrointestinal Disorder |
1.3% |
| Gastrointestinal Haemorrhage |
1.3% |
| Abdominal Discomfort |
1.0% |
| Arthralgia |
1.0% |
| Flatulence |
1.0% |
| Gastrointestinal Motility Disorder |
1.0% |
| Hypoaesthesia |
1.0% |
| Ocular Hyperaemia |
1.0% |
|
| Secondary |
| Hyperphosphataemia |
32.0% |
| Product Used For Unknown Indication |
31.1% |
| Hypertension |
6.6% |
| Anaemia |
4.9% |
| Headache |
3.3% |
| Hiv Infection |
2.5% |
| Device Occlusion |
1.6% |
| Dialysis |
1.6% |
| Hyperparathyroidism Secondary |
1.6% |
| Iron Deficiency |
1.6% |
| Migraine |
1.6% |
| Nausea |
1.6% |
| Prophylaxis |
1.6% |
| Pyrexia |
1.6% |
| Renal Failure Chronic |
1.6% |
| Toothache |
1.6% |
| Acidosis |
0.8% |
| Herpes Zoster |
0.8% |
| Pain |
0.8% |
| Renal Failure |
0.8% |
|
| Hyperphosphataemia |
25.0% |
| Constipation |
20.8% |
| Gastritis |
8.3% |
| Pruritus |
8.3% |
| Arthralgia |
4.2% |
| Diarrhoea |
4.2% |
| Dysphagia |
4.2% |
| Gastrointestinal Disorder |
4.2% |
| Hypoaesthesia |
4.2% |
| Malaise |
4.2% |
| Metabolic Encephalopathy |
4.2% |
| Pancreatitis Acute |
4.2% |
| Tinnitus |
4.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
40.7% |
| Nephrogenic Anaemia |
16.1% |
| Drug Use For Unknown Indication |
4.7% |
| Hyperparathyroidism Secondary |
4.2% |
| Insomnia |
4.2% |
| Pain |
3.8% |
| Multiple Myeloma |
3.4% |
| Depression |
3.0% |
| Hypertension |
3.0% |
| Abdominal Discomfort |
2.1% |
| Peritoneal Dialysis |
2.1% |
| Plasma Cell Myeloma |
2.1% |
| Respiratory Tract Congestion |
2.1% |
| Prophylaxis Of Nausea And Vomiting |
1.7% |
| Anaemia |
1.3% |
| Anxiety |
1.3% |
| Constipation |
1.3% |
| Haemolytic Uraemic Syndrome |
1.3% |
| Antiviral Prophylaxis |
0.8% |
| Back Pain |
0.8% |
|
| Cerebral Ischaemia |
13.2% |
| Spinal Compression Fracture |
10.5% |
| Angina Pectoris |
7.9% |
| Fatigue |
7.9% |
| Cardiac Failure |
5.3% |
| Chronic Myeloid Leukaemia |
5.3% |
| Lethargy |
5.3% |
| Moaning |
5.3% |
| Myocardial Infarction |
5.3% |
| Pneumonia |
5.3% |
| Sepsis |
5.3% |
| Bipolar I Disorder |
2.6% |
| Blood Glucose Increased |
2.6% |
| Cerebral Infarction |
2.6% |
| Cerebrovascular Accident |
2.6% |
| Condition Aggravated |
2.6% |
| Constipation |
2.6% |
| Death |
2.6% |
| Diarrhoea |
2.6% |
| Dizziness |
2.6% |
|
